Artivion, Inc. (AORT)
19.10
-0.30
(-1.55%)
USD |
NYSE |
Nov 13, 16:00
19.10
0.00 (0.00%)
Pre-Market: 19:59
Artivion Enterprise Value : 1.291B for Nov. 13, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 1.291B |
| November 12, 2026 | 1.305B |
| November 11, 2026 | 1.339B |
| November 10, 2026 | 1.357B |
| November 09, 2026 | 1.366B |
| November 06, 2026 | 1.345B |
| November 05, 2026 | 1.594B |
| November 04, 2026 | 1.649B |
| November 03, 2026 | 1.515B |
| November 02, 2026 | 1.509B |
| October 30, 2026 | 1.460B |
| October 29, 2026 | 1.502B |
| October 28, 2026 | 1.477B |
| October 27, 2026 | 1.478B |
| October 26, 2026 | 1.480B |
| October 23, 2026 | 1.495B |
| October 22, 2026 | 1.528B |
| October 21, 2026 | 1.476B |
| October 20, 2026 | 1.485B |
| October 19, 2026 | 1.446B |
| October 16, 2026 | 1.421B |
| October 15, 2026 | 1.426B |
| October 14, 2026 | 1.409B |
| October 13, 2026 | 1.401B |
| October 12, 2026 | 1.422B |
| Date | Value |
|---|---|
| October 09, 2026 | 1.396B |
| October 08, 2026 | 1.393B |
| October 07, 2026 | 1.413B |
| October 06, 2026 | 1.424B |
| October 05, 2026 | 1.462B |
| October 02, 2026 | 1.447B |
| October 01, 2026 | 1.429B |
| September 30, 2026 | 1.472B |
| September 29, 2026 | 1.444B |
| September 28, 2026 | 1.448B |
| September 25, 2026 | 1.433B |
| September 24, 2026 | 1.452B |
| September 23, 2026 | 1.476B |
| September 22, 2026 | 1.506B |
| September 21, 2026 | 1.481B |
| September 18, 2026 | 1.468B |
| September 17, 2026 | 1.493B |
| September 16, 2026 | 1.549B |
| September 15, 2026 | 1.566B |
| September 14, 2026 | 1.546B |
| September 11, 2026 | 1.552B |
| September 10, 2026 | 1.531B |
| September 09, 2026 | 1.559B |
| September 08, 2026 | 1.554B |
| September 04, 2026 | 1.576B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Abbott Laboratories | 215.41B |
| AngioDynamics, Inc. | 480.34M |
| Alphatec Holdings, Inc. | 1.622B |
| AtriCure, Inc. | 2.804B |
| Baxter International, Inc. | 19.36B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -7.916M |
| Revenue (Quarterly) | 123.79M |
| Total Expenses (Quarterly) | 131.71M |
| EPS Diluted (Quarterly) | -0.1625 |
| Gross Profit Margin (Quarterly) | 57.52% |
| Profit Margin (Quarterly) | -6.39% |
| Earnings Yield | -1.90% |
| Operating Earnings Yield | 2.52% |
| Normalized Earnings Yield | -0.6162 |